The 5-HT6 serotonin receptor antagonist SB-271046 attenuates the development and expression of nicotine-induced locomotor sensitisation in Wistar rats

Neuropharmacology

Volumn 61, Issue 3, 2011, Pages 451-457

  De Bruin, N M W J ^a   Kloeze, B M ^a   McCreary, A C ^a  

^a Chemical Design and Synthesis Unit   (Netherlands)

Author keywords

Development and expression of nicotine sensitisation; Locomotor activity; SB 271046; Serotonin 5 HT 6 antagonist; Wistar rats

Indexed keywords

5 CHLORO N [4 METHOXY 3 (1 PIPERAZINYL)PHENYL] 3 METHYL 2 BENZOTHIOPHENESULFONAMIDE; NICOTINE; SEROTONIN 6 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SULFONAMIDE; THIOPHENE DERIVATIVE;

ANIMAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG SENSITIZATION; HABITUATION; LOCOMOTION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ADDICTION; ANIMAL; CHEMISTRY; DRUG EFFECT; MOTOR ACTIVITY; RECURRENT DISEASE; TIME; WISTAR RAT; WITHDRAWAL SYNDROME; ANIMAL EXPERIMENT; BEHAVIOR; CAGE; CONFERENCE PAPER; EXPERIMENTAL STUDY; SENSITIZATION;

ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; NICOTINE; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECURRENCE; SEROTONIN ANTAGONISTS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; SULFONAMIDES; THIOPHENES; TIME FACTORS;

EID: 79958115578     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.01.045     Document Type: Article

References (60)

1. D.N. Abrous, W. Adriani, M.-F. Montaron, C. Aurousseau, G. Rougon, M. Le Moal, and P.V. Piazza Nicotine self-administration impairs hippocampal plasticity J. Neurosci. 2 2002 3656 3662 (Pubitemid 37465770)
2. T.B. Baker, T.H. Brandon, and L. Chassin Motivational influences on cigarette smoking Annu. Rev. Psychol. 55 2004 463 491
3. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacol 38 8 1999 1083 1152 (Pubitemid 29292403)
4. M.E.M. Benwell, and D.J.K. Balfour The effects of acute and repeated nicotine treatment on accumbens dopamine and locomotor activity Br. J. Pharmacol. 105 1992 849 856
5. 6 receptor alters acute responses to ethanol Neuropsychopharmacol. 31 2006 1801 1813 (Pubitemid 44106712)
6. Centre for Disease Control and Prevention (CDC) Tobacco use among adults - United States, 2005 MMWR Morbidity Mortality Weekly Rep. 55 2006 1145 1148
7. J.P. Changeux Nicotine addiction and nicotinic receptors: lessons from genetically modified mice Nature. Rev. Neurosci. 11 2010 389 401
8. P.B. Clarke, and R. Kumar The effects of nicotine on locomotor activity in non-tolerant and tolerant rats Brit. J. Pharmacol. 78 2 1983 329 337 (Pubitemid 13192204)
9. W.A. Corrigall, and K.M. Coen Nicotine maintains robust self-administration in rats on a limited access schedule Psychopharmacology 99 1989 473 478 (Pubitemid 19273101)
10. H. Cremer, G. Chazal, P.M. Lledo, G. Rougon, M.F. Montaron, W. Mayo, M. Le Moal, and D.N. Abrous PSA-NCAM: an important regulator of hippocampal plasticity Int. J. Dev. Neurosci. 18 2000 213 220 (Pubitemid 30129195)
11. L.A. Dawson, H.Q. Nguyen, and P. Li The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus Neuropsychopharmacol 25 5 2001 662 668 (Pubitemid 32995948)
12. L.A. Dawson, H.Q. Nguyen, and P. Li Potentiation of amphetamine -induced changes in dopamine and 5-HT by a 5-HT6 receptor antagonist Brain Res. Bull. 59 2003 513 521 (Pubitemid 36173607)
13. N.M.W.J. De Bruin, A. Van Loevezijn, J. Wijnen, A.H.J. Herremans, and C.G. Kruse Use of 5-HT6 Antagonists to Prevent Relapse into Addiction 2008 United States Patent Application 20080171779
14. T.J. De Vries, A.N. Schoffelmeer, R. Binnekade, H. Raaso, and L.J. Vanderschuren Relapse to cocaine- and heroin seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization Neuropsychopharmacol 26 2002 18 26 (Pubitemid 34075273)
15. G. Di Chiara Drug addiction as dopamine-dependent associative learning disorder Eur. J. Pharmacol. 75 1999 13 30 (Pubitemid 29317589)
16. J.R. Di Franza, and R.J. Wellman Sensitization to nicotine: how the animal literature might inform future human research Nicotine Tob. Res. 9 2007 9 20 (Pubitemid 47009040)
17. 2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration J. Neurochem. 89 2004 418 429 (Pubitemid 38495990)
18. 6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine Biol. Psych 63 2008 207 213 (Pubitemid 350299315)
19. 2 receptor subtypes to the hyperlocomotive effects of cocaine: acute and chronic pharmacological analyses J. Pharmacol. Exp. Ther. 310 2004 1246 1254 (Pubitemid 39108947)
20. 2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine Pharmacol. Biochem. Behav. 71 2002 745 756 (Pubitemid 34219225)
21. 2C receptors in rat prefrontal cortex J. Pharmacol. Exp. Ther. 306 2003 734 743 (Pubitemid 36886175)
22. K. Fijal, A.C. McCreary, K. Wydra, M. Papp, P. Bienkowski, J. Kotliska, and M. Filip Effects of serotinin (5-HT)6 reeceptor ligands on responding for cocaine reward and seeking in rats. Pharmacol. Reports Pharmacol Rep 62 6 2010 1005 1014
23. 6 receptor antagonists SB-271046 and SB-399885 potentiate NCAM PSA immunolabeling of dentate granule cells, but not neurogenesis, in the hippocampal formation of mature Wistar rats Neuropharmacol 54 2008 1166 1174
24. 6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats Neuropsychopharmacol 29 2004 93 100 (Pubitemid 38068018)
25. K.C.F. Fone An update on the role of 5-hydroxytryptamine 6 receptors in cognitive function Neuropharmacol 55 2008 1015 1022
26. K.J. Frantz, K.J. Hansson, D.G. Stouffer, and L.H. Parsons 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine Neuropharmacol 42 2002 170 180 (Pubitemid 34137020)
27. 6 receptor-like material in the rat central nervous system Brain Res. 746 1997 207 219 (Pubitemid 27060349)
28. S.R. Goldberg, and J.E. Henningfield Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection Pharmacol. Biochem. Behav 30 1988 227 234 (Pubitemid 19268815)
29. 2C receptors reduces the locomotor and rewarding effects of nicotine Psychopharmacol 157 2001 292 298 (Pubitemid 32905571)
30. J. Kelsey, and S. Calabro Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats Psychopharmacol 198 2008 461 466 (Pubitemid 351754670)
31. 6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex Synapse 51 2004 58 64
32. B. Le Foll, and S.R. Goldberg Nicotine as a typical drug of abuse in experimental animals and humans Psychopharmacology (Berl) 184 2006 367 381 (Pubitemid 43255853)
33. Z. Li, J.R. DiFranza, R.J. Wellman, P. Kulkarni, and J.A. King Imaging brain activation in nicotine-sensitized rats Brain Res. 1199 2008 91 99
34. S.D. Mahajan, R. Aalinkeel, J.L. Reynolds, B.B. Nair, D.E. Sykes, Z. Hu, A. Bonoiu, H. Ding, P.N. Prasad, and S.A. Schwartz Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopaminergic pathway for the treatment of opiate addiction Int. Rev. Neurobiol. 88 2009 199 222
35. 6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat Brit. J. Pharmacol 155 2008 434 440
36. S.P. Marshall, A. Adhikari, M.W. Nason, L. Role, and J.A. Gordon Altered Theta and Gamma Activity Profiles in the Ventral Hippocampal-Accumbal Pathway of Type III Neuregulin 1 Heterozygous Mice 2009 Soc. for Neurosci. Ann. Meet. (Chicago, Illinois) Abstract 102.9
37. L.R. McMahon, and K.A. Cunningham Antagonism of 5-hydroxytryptamine 2A receptors attenuates the behavioral effects of cocaine in rats J. Pharmacol. Exp. Ther. 297 2001 357 363 (Pubitemid 32242596)
38. D.K. Miller, L.H. Wilkins, M.T. Bardo, P.A. Crooks, and L.P. Dwoskin Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism Psychopharmacol 156 2001 469 476 (Pubitemid 32695857)
39. A.H. Mokdad, J.S. Marks, D.F. Stroup, and J.L. Gerberding Actual causes of death in the United States, 2000 J. Am. Med. Assoc. 291 2004 1238 1245 (Pubitemid 38541668)
40. F.J. Monsma, Y. Shen, R.P. Ward, M.W. Hamblin, and D.R. Sibley Cloning and expression of a novel serotonin receptor with high-affinity for tricyclic psychotropic drugs Mol. Pharmacol. 43 1993 320 327 (Pubitemid 23081986)
41. M. Nisell, G.G. Nomikos, P. Hertel, G. Panagis, and T.H. Svensson Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat Synapse 22 1986 369 381
42. 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment Eur. J.Pharmacol 420 2001 45 54 (Pubitemid 32539094)
43. P. Olausson, J.A. Engel, and B. Soderpalm Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake Pharmacol. Biochem. Behav. 71 2002 757 771 (Pubitemid 34219226)
44. B. Pouzet, M. Didriksen, and J. Arnt Effects of the 5-HT(6) receptor antagonist, SB-271046, in animal models for schizophrenia Pharmacol. Biochem. Behav. 71 2002 635 643 (Pubitemid 34219214)
45. 6 receptor antagonist J. Med. Chem. 46 2003 1273 1276 (Pubitemid 36428233)
46. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Rev. 18 1983 247 291
47. T.E. Robinson, and K.C. Berridge The incentive sensitization theory of addiction: some current issues Phil. Trans. R. Soc. Bull. 363 2008 3137 3146
48. J.A. Rosecrans, and H.F. Villanueva Discriminative stimulus properties of nicotine: mechanisms of transduction NIDA Res. Monogr 116 1991 101 116 (Pubitemid 23089665)
49. C. Routledge, S.M. Bromidge, S.F. Moss, G.W. Price, W. Hirst, H. Newman, G. Riley, T. Gager, T. Stean, N. Upton, S.E. Clarke, A.M. Brown, and D.N. Middlemiss Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist Brit. J. Pharmacol. 130 2000 1606 1612 (Pubitemid 30611938)
50. 6) receptor - molecular cloning, localization and stimulation of cAMP accumulation Bioch.Biophys. Res. Comm. 193 1993 268 276 (Pubitemid 23199942)
51. 6 receptor agonists: WAY-181187 and WAY-208466 Neuropsychopharmacol 33 2007 1323 1335
52. S. Shirazi-Southall, D.E. Rodriguez, and G.G. Nomikos Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux on the hippocampus of the rat Neuropsychopharmacol 26 2002 583 594 (Pubitemid 34260977)
53. M. Shoaib, I.P. Stolerman, and R.C. Kumar Nicotine-induced place preferences following prior nicotine exposure in rats Psychopharmacology 113 1994 445 452 (Pubitemid 24150492)
54. I.P. Stolerman, R. Fink, and M.E. Jarvik Acute and chronic tolerance to nicotine measured activity in rats Psychopharmacologia 30 1973 329 342
55. 6 antagonism attenuates cue-induced relapse to cocaine seeking without affecting cocaine reinforcement Int. J. Neuropsychopharmacol. 13 2010 961 965
56. P. Vezina, D.S. McGehee, and W.N. Green Exposure to nicotine and sensitization of nicotine-induced behaviors Pro. Neuropsychopharmaco. Biol. Psych. 31 8 2007 1625 1638 (Pubitemid 47625708)
57. 6 with neuropeptides in rat striatum J. Comp. Neurol. 370 1996 405 414 (Pubitemid 26235237)
58. 6 receptors Curr.Drug Targets CNS Neurol. Dis. 3 2004 59 79 (Pubitemid 38854902)
59. M. Zaniewska, M. Filip, A.C. McCreary, E. Nowak, and E. Przegalinski Effects of the serotonin2C receptor ligands in the nicotine-evoked conditioned hyperlocomotion and sensitization Eur. Neuropsychopharmacol. 2007 S46
60. M. Zaniewska, A.C. Mccreary, K. Wydra, and M. Filip Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment Synapse 64 7 2010 511 519